PFG
MRK icon

Piershale Financial Group’s Merck MRK Stock Holding History

Piershale Financial Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40
Closed -$4.26K – 287
2023
Q1 		$4.26K Buy
40
+20
+100% +$2.16K ﹤0.01% 187
2022
Q4 		$2.22K Buy
+20
New +$2.04K ﹤0.01% 243
2016
Q4 		– Sell
-168
Closed -$10K – 92
2016
Q3 		$10K Hold
168
– – 0.01% 90
2016
Q2 		$9K Hold
168
– – 0.01% 94
2016
Q1 		$8K Sell
168
-403
-71% -$19.7K ﹤0.01% 89
2015
Q4 		$29K Buy
+571
New +$28.8K 0.02% 57
2014
Q3 		– Sell
-121
Closed -$7K – 167
2014
Q2 		$7K Buy
+121
New +$6.6K 0.01% 109

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Piershale Financial Group's MRK Position: Q2 2023 in Review

Piershale Financial Group sold out of Merck (MRK) in Q2 2023, closing a stake of 40 shares — an estimated $4.26K sold.

Piershale Financial Group first reported a position in MRK in Q2 2014 and held it in 7 quarters. The position peaked at $29K in Q4 2015. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • Piershale Financial Group reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
  • Piershale Financial Group sold 40 Merck shares in Q2 2023, an estimated $4.26K.
  • Piershale Financial Group first reported a position in Merck in Q2 2014 and held it in 7 quarters.
  • Piershale Financial Group's Merck position peaked at $29K in Q4 2015.
  • 3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Piershale Financial Group's 13F filing for Q2 2023, filed 6 Jul 2023.